ATE147793T1 - Überprüfungsteste - Google Patents
ÜberprüfungstesteInfo
- Publication number
- ATE147793T1 ATE147793T1 AT91917394T AT91917394T ATE147793T1 AT E147793 T1 ATE147793 T1 AT E147793T1 AT 91917394 T AT91917394 T AT 91917394T AT 91917394 T AT91917394 T AT 91917394T AT E147793 T1 ATE147793 T1 AT E147793T1
- Authority
- AT
- Austria
- Prior art keywords
- oncoprotein
- reporter gene
- pct
- transcription
- sec
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Tea And Coffee (AREA)
- Peptides Or Proteins (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Inspection Of Paper Currency And Valuable Securities (AREA)
- Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thin Film Transistor (AREA)
- Light Receiving Elements (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58678190A | 1990-09-24 | 1990-09-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE147793T1 true ATE147793T1 (de) | 1997-02-15 |
Family
ID=24347091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91917394T ATE147793T1 (de) | 1990-09-24 | 1991-09-20 | Überprüfungsteste |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5580721A (de) |
| EP (1) | EP0550592B1 (de) |
| JP (1) | JPH06503713A (de) |
| KR (1) | KR930703462A (de) |
| CN (1) | CN1065092A (de) |
| AT (1) | ATE147793T1 (de) |
| AU (1) | AU650677B2 (de) |
| CA (1) | CA2092000A1 (de) |
| CZ (1) | CZ49693A3 (de) |
| DE (1) | DE69124254T2 (de) |
| DK (1) | DK0550592T3 (de) |
| FI (1) | FI931268L (de) |
| HU (1) | HUT66827A (de) |
| IE (1) | IE913330A1 (de) |
| IL (1) | IL99546A0 (de) |
| NZ (1) | NZ239885A (de) |
| PT (1) | PT99033A (de) |
| WO (1) | WO1992005286A1 (de) |
| ZA (1) | ZA917616B (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5362623A (en) * | 1991-06-14 | 1994-11-08 | The John Hopkins University | Sequence specific DNA binding by p53 |
| EP0528827B1 (de) * | 1990-04-19 | 1996-09-04 | The General Hospital Corporation | Screening nach proteinpartnern und deren verwendung |
| US5322801A (en) * | 1990-04-19 | 1994-06-21 | The General Hospital Corporation | Protein partner screening assays and uses thereof |
| DK0593618T3 (da) * | 1991-06-27 | 1998-11-23 | Genelabs Tech Inc | Screeningsassay til påvisning af DNA-bindende molekyler |
| HK1004920A1 (en) * | 1993-01-21 | 1998-12-11 | President And Fellows Of Harvard College | Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound |
| US6824976B1 (en) | 1993-04-02 | 2004-11-30 | Rigel Pharmaceuticals, Inc. | Method for selective inactivation of viral replication |
| DE19502584C2 (de) * | 1994-01-28 | 1999-08-12 | Medigene Ag Ges Fuer Molekular | Verfahren zur Bestimmung der Aktivität eines regulatorischen Faktors sowie Verwendung dieses Verfahrens |
| US6051373A (en) * | 1994-12-07 | 2000-04-18 | Scriptgen Pharmaceuticals, Inc. | Methods for screening for inhibitors of the transcription-enhancing activity of the X protein of hepatitis B virus |
| NZ306767A (en) | 1995-04-11 | 2000-03-27 | Univ Johns Hopkins | Method of identifying molecular interactions employing counterselection and at least two hybrid molecules or two hybrid systems |
| US5637463A (en) * | 1995-05-04 | 1997-06-10 | Hoffmann-La Roche Inc. | Method to detect protein-protein interactions |
| KR100402836B1 (ko) * | 1995-05-11 | 2004-02-19 | 주식회사 엘지생명과학 | 단백질간의상호작용을조절하는물질의새로운탐색시스템 |
| US5569588A (en) * | 1995-08-09 | 1996-10-29 | The Regents Of The University Of California | Methods for drug screening |
| US6326140B1 (en) | 1995-08-09 | 2001-12-04 | Regents Of The University Of California | Systems for generating and analyzing stimulus-response output signal matrices |
| US5777888A (en) * | 1995-08-09 | 1998-07-07 | Regents Of The University Of California | Systems for generating and analyzing stimulus-response output signal matrices |
| US5861249A (en) * | 1996-04-23 | 1999-01-19 | Cold Spring Harbor Laboratory | Assays and reagents for identifying modulators of cdc25-mediated mitotic activation |
| US6083693A (en) | 1996-06-14 | 2000-07-04 | Curagen Corporation | Identification and comparison of protein-protein interactions that occur in populations |
| US5807708A (en) * | 1996-07-30 | 1998-09-15 | Millennium Pharmaceuticals, Inc. | Conservin nucleic acid molecules and compositions |
| US5928888A (en) * | 1996-09-26 | 1999-07-27 | Aurora Biosciences Corporation | Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities |
| US6623922B1 (en) * | 1997-02-14 | 2003-09-23 | Deltagen Proteomics | Methods for identifying, characterizing, and evolving cell-type specific CIS regulatory elements |
| US20040002079A1 (en) * | 1998-02-11 | 2004-01-01 | Gunn Robert B. | Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness |
| WO1999041371A1 (en) | 1998-02-13 | 1999-08-19 | Genetrace Systems, Inc. | Use of ribozymes for functionating genes |
| DE60028554T2 (de) | 1999-03-23 | 2007-05-16 | Chugai Seiyaku K.K. | Verfahren zum screenen nach gegen krebs gerichteten medikamenten |
| US6689558B2 (en) | 2000-02-08 | 2004-02-10 | Sangamo Biosciences, Inc. | Cells for drug discovery |
| WO2003092581A2 (en) * | 2001-07-16 | 2003-11-13 | Hk Pharmaceuticals, Inc. | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| AU2003224674A1 (en) * | 2002-03-11 | 2003-09-29 | Hk Pharmaceuticals, Inc. | Compounds and methods for analyzing the proteome |
| US20040086945A1 (en) * | 2002-06-03 | 2004-05-06 | The Procter & Gamble Company | Hairless protein-interacting partner complexes and methods thereto |
| WO2004064972A2 (en) * | 2003-01-16 | 2004-08-05 | Hk Pharmaceuticals, Inc. | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| WO2005054870A2 (en) * | 2003-11-26 | 2005-06-16 | Vanderbilt University | METHODS FOR ASSESSING p19-Arf INTERACTIONS WITH cMyc |
| CN105802983B (zh) * | 2016-03-28 | 2019-12-03 | 中国科学院青岛生物能源与过程研究所 | 一种产脂肪烃基因的高通量筛选方法及获得的突变体与应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4833080A (en) * | 1985-12-12 | 1989-05-23 | President And Fellows Of Harvard College | Regulation of eucaryotic gene expression |
| US4981784A (en) * | 1987-12-02 | 1991-01-01 | The Salk Institute For Biological Studies | Retinoic acid receptor method |
| US4980281A (en) * | 1988-02-10 | 1990-12-25 | Housey Gerard M | Method of screening for protein inhibitors and activators |
| DE68921918T2 (de) * | 1988-05-09 | 1995-09-07 | Univ Temple | Verfahren zur Voraussage der Wirksamkeit einer antineoplastichen Behandlung bei einzelnen Patienten. |
| AU7667191A (en) * | 1990-04-19 | 1991-11-11 | General Hospital Corporation, The | Screening assays for compounds which inhibit the binding of c-myc to dna |
| WO1992013091A1 (en) * | 1991-01-18 | 1992-08-06 | Oncogene Science, Inc. | Methods of transcriptionally modulating expression of oncogenes and tumor suppressor genes |
-
1991
- 1991-09-20 FI FI931268A patent/FI931268L/fi not_active Application Discontinuation
- 1991-09-20 WO PCT/US1991/006839 patent/WO1992005286A1/en not_active Ceased
- 1991-09-20 EP EP91917394A patent/EP0550592B1/de not_active Expired - Lifetime
- 1991-09-20 AU AU86272/91A patent/AU650677B2/en not_active Expired - Fee Related
- 1991-09-20 HU HU9300822A patent/HUT66827A/hu unknown
- 1991-09-20 CA CA002092000A patent/CA2092000A1/en not_active Abandoned
- 1991-09-20 JP JP3516071A patent/JPH06503713A/ja active Pending
- 1991-09-20 US US08/050,198 patent/US5580721A/en not_active Expired - Fee Related
- 1991-09-20 KR KR1019930700892A patent/KR930703462A/ko not_active Withdrawn
- 1991-09-20 NZ NZ239885A patent/NZ239885A/en unknown
- 1991-09-20 DE DE69124254T patent/DE69124254T2/de not_active Expired - Fee Related
- 1991-09-20 AT AT91917394T patent/ATE147793T1/de not_active IP Right Cessation
- 1991-09-20 DK DK91917394.8T patent/DK0550592T3/da active
- 1991-09-20 CZ CS93496A patent/CZ49693A3/cs unknown
- 1991-09-21 CN CN91110638A patent/CN1065092A/zh active Pending
- 1991-09-22 IL IL99546A patent/IL99546A0/xx unknown
- 1991-09-23 IE IE333091A patent/IE913330A1/en unknown
- 1991-09-24 PT PT99033A patent/PT99033A/pt not_active Application Discontinuation
- 1991-09-24 ZA ZA917616A patent/ZA917616B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI931268A0 (fi) | 1993-03-23 |
| JPH06503713A (ja) | 1994-04-28 |
| CZ49693A3 (en) | 1994-02-16 |
| CA2092000A1 (en) | 1992-03-25 |
| IL99546A0 (en) | 1992-08-18 |
| EP0550592A4 (en) | 1994-12-07 |
| ZA917616B (en) | 1993-09-24 |
| US5580721A (en) | 1996-12-03 |
| EP0550592B1 (de) | 1997-01-15 |
| KR930703462A (ko) | 1993-11-30 |
| AU650677B2 (en) | 1994-06-30 |
| CN1065092A (zh) | 1992-10-07 |
| PT99033A (pt) | 1992-08-31 |
| DE69124254T2 (de) | 1997-06-12 |
| WO1992005286A1 (en) | 1992-04-02 |
| DE69124254D1 (de) | 1997-02-27 |
| HU9300822D0 (en) | 1993-11-29 |
| HUT66827A (en) | 1995-01-30 |
| FI931268A7 (fi) | 1993-04-21 |
| EP0550592A1 (de) | 1993-07-14 |
| IE913330A1 (en) | 1992-02-25 |
| FI931268L (fi) | 1993-04-21 |
| DK0550592T3 (da) | 1997-07-07 |
| AU8627291A (en) | 1992-04-15 |
| NZ239885A (en) | 1993-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69124254D1 (de) | Überprüfungsteste | |
| FI962879A0 (fi) | Sinkkisormiproteiinijohdannaisia ja niiden menetelmiä | |
| NO990338D0 (no) | Celleadhesjonsinhibitorer | |
| TR199901667T2 (xx) | 3-Heterosiklil-ikame edilmi� benzoil t�revleri | |
| DE69534549D1 (de) | Kombination von retroviralen proteasehennern | |
| BR9609851A (pt) | Equipamento para conservação dos dados de produto | |
| ATE287402T1 (de) | Nanomolare, non-peptidische inhibitoren von cathepsin d | |
| DE59900730D1 (de) | Korrosionsinhibitoren enthaltender Injektionszement | |
| MX9709360A (es) | Metodo para la deteccion de compuestos que modulan los efectos de la proteina de la obesidad. | |
| SE8001605L (sv) | Kromogent material | |
| DE3580024D1 (de) | Verfahren zum maschinellen auftragen von klebstoff auf buchblockruecken. | |
| DE3585350D1 (de) | Vorrichtung zum datenschutz von rechnersystemen. | |
| TR199900963T2 (xx) | Obez (OB) proteininin etkilerine uyan bile�iklerin tespit edilmesi i�in metot. | |
| DE59702615D1 (de) | Vorrichtung zum aufbringen von klebeband auf einen druckzylinder | |
| DE69328080D1 (de) | Verfahren zum hochempfindlichen nachweis von aminosäurederivaten | |
| SE8403440L (sv) | Anordning vid berplocknilngsapparater | |
| SE8401783L (sv) | Anordning vid stapling av seckar | |
| SE8306718D0 (sv) | Anordning vid sorteringsverk for timmerstockar | |
| KR900007629A (ko) | 자기발색형 감압기록지용 도공액 조성물 | |
| MX9700116A (es) | Uso de leucotriarilmetanos para la marcacion de hidrocarburos. | |
| DE69628134D1 (de) | Auf der inhibierung von phosphatasen beruhendes verfahren zum nachweis und zur quantifizierung von diarrhoetischem schalentiergift | |
| DE69729961D1 (de) | Inhibitorprotein der dna-gyrase. | |
| SE8406078L (sv) | Anordning vid trenings- och testapparat for hestar | |
| SE8404947L (sv) | Anordning vid hantering av ampuller innehallande giftiga emnen | |
| SE8104267L (sv) | Kartongbrytningsenhet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |